-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ea4q31T5FEg5xtrRyQXYESWH9nPecJYtywlFGac/xOeBCB0Gj6/hlnceCdJ9QtW7 IktqcuFh79znCpEDV7v43A== 0000950144-02-001682.txt : 20020414 0000950144-02-001682.hdr.sgml : 20020414 ACCESSION NUMBER: 0000950144-02-001682 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020207 ITEM INFORMATION: Change in fiscal year FILED AS OF DATE: 20020220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAXXIM MEDICAL INC CENTRAL INDEX KEY: 0000858660 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 760291634 STATE OF INCORPORATION: TX FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-92825-01 FILM NUMBER: 02553905 BUSINESS ADDRESS: STREET 1: 10300 49TH ST N CITY: CLEARWATER STATE: FL ZIP: 33762 BUSINESS PHONE: 7275612100 MAIL ADDRESS: STREET 1: 10300 49TH STREET NORTH CITY: CLEARWATER STATE: FL ZIP: 33762 8-K 1 g74350e8-k.htm MAXXIM MEDICAL, INC. e8-k
Table of Contents

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): February 20, 2002 (February 7, 2002)

MAXXIM MEDICAL, INC.


(Exact Name of Registrant as Specified in Charter)
         
Texas   0-18208   76-0291634

(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

950 Winter Street, Suite 2900, Waltham, Massachusetts             02451


(Address of Principal Executive Offices)                         (Zip Code)

Registrant’s telephone number, including area code (781) 906-0700

 


Item 8. Change in Fiscal Year
Signature


Table of Contents

Item 8. Change in Fiscal Year

On February 7, 2002, Maxxim Medical, Inc. decided to change its fiscal year-end from a fiscal year ending on the Sunday nearest to October 31 to a fiscal year ending on the Sunday nearest to December 31. A report on Form 10-K, covering the transition period from October 29, 2001 to December 30, 2001, will be filed with the Securities and Exchange Commission in accordance with its rules and regulations.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
  Maxxim Medical, Inc.
 
Date: February 20, 2002 By: /s/ Mark S. Sellers  
 
    Mark S. Sellers
Vice Chairman and
Chief Financial Officer

  -----END PRIVACY-ENHANCED MESSAGE-----